Porphyria Cutanea Tarda
Also known as: Cutanea porphyria tarda / Cutaneous hepatic porphyria / Porphyria cutanea tarda (disorder) / Porphyria non-acute
Drug | Drug Name | Drug Description |
---|---|---|
DB00608 | Chloroquine | An antimalarial drug used to treat susceptible infections with P. vivax, P. malariae, P. ovale, and P. falciparum. It is also used for second line treatment for rheumatoid arthritis. |
DB01611 | Hydroxychloroquine | An antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01609 | Deferasirox | 2 | Unknown Status | 1 |
DB01611 | Hydroxychloroquine | 2 | Completed | 1 |
DB09027 | Ledipasvir | 2 | Completed | 1 |
DB08934 | Sofosbuvir | 2 | Completed | 1 |
DB01609 | Deferasirox | 3 | Completed | 1 |